Advertisement

Topics

Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira

17:05 EDT 18 Oct 2016 | SCRIP

Six-year-old biosimilar specialist could be first company to launch a biosimilar version of Neulasta, but the possibility of a biosimilar...

      

Related Stories

 

Original Article: Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira

NEXT ARTICLE

More From BioPortfolio on "Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...